JP2024542939A5 - - Google Patents
Info
- Publication number
- JP2024542939A5 JP2024542939A5 JP2024522269A JP2024522269A JP2024542939A5 JP 2024542939 A5 JP2024542939 A5 JP 2024542939A5 JP 2024522269 A JP2024522269 A JP 2024522269A JP 2024522269 A JP2024522269 A JP 2024522269A JP 2024542939 A5 JP2024542939 A5 JP 2024542939A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163256511P | 2021-10-15 | 2021-10-15 | |
| US63/256,511 | 2021-10-15 | ||
| PCT/US2022/078180 WO2023064947A1 (en) | 2021-10-15 | 2022-10-15 | Antibodies and methods of using thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542939A JP2024542939A (ja) | 2024-11-19 |
| JP2024542939A5 true JP2024542939A5 (https=) | 2025-10-22 |
Family
ID=84331799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522269A Pending JP2024542939A (ja) | 2021-10-15 | 2022-10-15 | 抗体及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240425572A1 (https=) |
| EP (1) | EP4415822A1 (https=) |
| JP (1) | JP2024542939A (https=) |
| CA (1) | CA3234162A1 (https=) |
| IL (1) | IL311963A (https=) |
| WO (1) | WO2023064947A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026006341A1 (en) | 2024-06-24 | 2026-01-02 | Regenxbio Inc. | Microdystrophin gene therapy administration for treatment of dystrophinopathies |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4588585A (en) | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5681718A (en) | 1986-03-14 | 1997-10-28 | Celltech Limited | Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| MX9204374A (es) | 1991-07-25 | 1993-03-01 | Idec Pharma Corp | Anticuerpo recombinante y metodo para su produccion. |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US6174666B1 (en) | 1992-03-27 | 2001-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of eliminating inhibitory/instability regions from mRNA |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| JP2003531588A (ja) | 2000-04-11 | 2003-10-28 | ジェネンテック・インコーポレーテッド | 多価抗体とその用途 |
| GB0216648D0 (en) | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
| US20080187954A1 (en) | 2004-03-10 | 2008-08-07 | Lonza Ltd. | Method For Producing Antibodies |
| CA2581208A1 (en) | 2004-08-30 | 2006-03-09 | Lonza Biologics Plc. | Affinity- plus ion exchange- chromatography for purifying antibodies |
| US7691980B2 (en) | 2007-01-09 | 2010-04-06 | Bio-Rad Laboratories, Inc. | Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers |
| JP6157046B2 (ja) | 2008-01-07 | 2017-07-05 | アムジェン インコーポレイテッド | 静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法 |
| EP2238154B1 (en) | 2008-01-18 | 2015-09-16 | Bio-Rad Laboratories, Inc. | Enhanced purification of phosphorylated and non-phosphorylated biomolecules by apatite chromatography |
| US10093733B2 (en) | 2014-12-11 | 2018-10-09 | Abbvie Inc. | LRP-8 binding dual variable domain immunoglobulin proteins |
| TWI908746B (zh) | 2019-11-28 | 2025-12-21 | 美商銳進科斯生物股份有限公司 | 微小肌縮蛋白基因療法之構築體及其用途 |
| US20240003898A1 (en) * | 2020-10-30 | 2024-01-04 | Pfizer Inc. | Methods for measuring dystrophin in tissue samples |
-
2022
- 2022-10-15 US US18/701,201 patent/US20240425572A1/en active Pending
- 2022-10-15 JP JP2024522269A patent/JP2024542939A/ja active Pending
- 2022-10-15 CA CA3234162A patent/CA3234162A1/en active Pending
- 2022-10-15 WO PCT/US2022/078180 patent/WO2023064947A1/en not_active Ceased
- 2022-10-15 EP EP22802457.6A patent/EP4415822A1/en active Pending
- 2022-10-15 IL IL311963A patent/IL311963A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112225806B (zh) | 一种人源抗新型冠状病毒（SARS-CoV-2）的中和活性单克隆抗体 | |
| JP2023529417A5 (https=) | ||
| JP6081699B2 (ja) | Ｉｌ−２８ｂの分析方法 | |
| JP7245373B2 (ja) | 抗体の抗原に対する親和性を制御する方法、抗原に対する親和性が改変された抗体及びその製造方法 | |
| CA3069035C (en) | Improved rep protein for use in a diagnostic assay | |
| CN118909110A (zh) | Pcna结合蛋白、制备方法和应用 | |
| AU2009312731B2 (en) | Antibodies to modified human IGF-1/E peptides | |
| JP5821198B2 (ja) | 抗ｉｌ２８ｂ抗体及びこれを用いたｉｌ２８ｂの測定方法 | |
| JP2024542939A5 (https=) | ||
| JP2005507648A5 (https=) | ||
| JP6122777B2 (ja) | Ｆａｂ及びＦａｂ’分子の分析法 | |
| JP2024506409A5 (https=) | ||
| JP2024544885A5 (https=) | ||
| WO2023092314A1 (zh) | 结合bp特异性抗原肽的人源抗体、制备方法及用途 | |
| CN109890844B (zh) | 抗ninj-1抗体及其用途 | |
| CN119241700B (zh) | 核小体结合蛋白、制备方法和应用 | |
| KR20150077749A (ko) | 항 grs 모노클로날 항체 및 이의 용도 | |
| US20250067748A1 (en) | Host cell protein analysis of aav using proteominer technology | |
| JP7366411B2 (ja) | ヒトαディフェンシンＨＤ５を検出する方法及びキット、並びにこれらにおいて用いられる抗体 | |
| US20230331865A1 (en) | Antibodies for use in immunohistochemistry (ihc) protocols to diagnose cancer | |
| JPWO2023277122A5 (https=) | ||
| WO2025166285A1 (en) | Methods for characterizing anti-drug antibodies in samples | |
| CN121270712A (zh) | 抗Sp100抗体及其制备方法和应用 | |
| KR20160093503A (ko) | 항 crs 모노클로날 항체 및 이의 용도 | |
| CN119264254A (zh) | 抗降钙素原抗体及包括该抗体的检测试剂盒 |